Powder: -20°C for 3 years | In solvent: -80°C for 1 year
ZINC00640089 is a selective lipid carrier protein-2 (LCN2) inhibitor. ZINC00640089 inhibited cell proliferation and cell viability, and reduced AKT phosphorylation in SUM149 cells. ZINC00640089 can be used to study inflammatory breast cancer (IBC).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 60.00 | |
5 mg | In stock | $ 147.00 | |
10 mg | In stock | $ 218.00 | |
25 mg | In stock | $ 369.00 | |
50 mg | In stock | $ 543.00 | |
100 mg | In stock | $ 776.00 |
Description | ZINC00640089 is a selective lipid carrier protein-2 (LCN2) inhibitor. ZINC00640089 inhibited cell proliferation and cell viability, and reduced AKT phosphorylation in SUM149 cells. ZINC00640089 can be used to study inflammatory breast cancer (IBC). |
In vitro | In SUM149 cells, ZINC00640089 (0.01-100 µM; 72 h) decreases cell proliferation and cell viability [1]. Additionally, ZINC00640089 (1, 10 µM; 15 min, 1 h) reduces the levels of p-Akt in SUM149 cells [1]. |
Molecular Weight | 370.32 |
Formula | C20H13F3N2O2 |
CAS No. | 667880-11-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 10 mg/mL (27.00 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
ZINC00640089 667880-11-7 Cytoskeletal Signaling PI3K/Akt/mTOR signaling Akt inhibitor inhibit